These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28316055)

  • 1. A Comparison of Accelerated and Non-accelerated MRI Scans for Brain Volume and Boundary Shift Integral Measures of Volume Change: Evidence from the ADNI Dataset.
    Manning EN; Leung KK; Nicholas JM; Malone IB; Cardoso MJ; Schott JM; Fox NC; Barnes J;
    Neuroinformatics; 2017 Apr; 15(2):215-226. PubMed ID: 28316055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of changing from non-accelerated to accelerated MRI for follow-up in brain atrophy measurement.
    Leung KK; Malone IM; Ourselin S; Gunter JL; Bernstein MA; Thompson PM; Jack CR; Weiner MW; Fox NC;
    Neuroimage; 2015 Feb; 107():46-53. PubMed ID: 25481794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.
    Fujishima M; Kawaguchi A; Maikusa N; Kuwano R; Iwatsubo T; Matsuda H; ;
    J Alzheimers Dis; 2017; 56(1):75-88. PubMed ID: 27911297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease.
    Vemuri P; Senjem ML; Gunter JL; Lundt ES; Tosakulwong N; Weigand SD; Borowski BJ; Bernstein MA; Zuk SM; Lowe VJ; Knopman DS; Petersen RC; Fox NC; Thompson PM; Weiner MW; Jack CR;
    Neuroimage; 2015 Jun; 113():61-9. PubMed ID: 25797830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.
    Leung KK; Bartlett JW; Barnes J; Manning EN; Ourselin S; Fox NC;
    Neurology; 2013 Feb; 80(7):648-54. PubMed ID: 23303849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistent multi-time-point brain atrophy estimation from the boundary shift integral.
    Leung KK; Ridgway GR; Ourselin S; Fox NC;
    Neuroimage; 2012 Feb; 59(4):3995-4005. PubMed ID: 22056457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common MRI acquisition non-idealities significantly impact the output of the boundary shift integral method of measuring brain atrophy on serial MRI.
    Preboske GM; Gunter JL; Ward CP; Jack CR
    Neuroimage; 2006 May; 30(4):1196-202. PubMed ID: 16380273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.
    Risacher SL; Anderson WH; Charil A; Castelluccio PF; Shcherbinin S; Saykin AJ; Schwarz AJ;
    Neurology; 2017 Nov; 89(21):2176-2186. PubMed ID: 29070667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Your algorithm might think the hippocampus grows in Alzheimer's disease: Caveats of longitudinal automated hippocampal volumetry.
    Sankar T; Park MTM; Jawa T; Patel R; Bhagwat N; Voineskos AN; Lozano AM; Chakravarty MM;
    Hum Brain Mapp; 2017 Jun; 38(6):2875-2896. PubMed ID: 28295799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection.
    Leung KK; Clarkson MJ; Bartlett JW; Clegg S; Jack CR; Weiner MW; Fox NC; Ourselin S;
    Neuroimage; 2010 Apr; 50(2):516-23. PubMed ID: 20034579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric comparison of hippocampal subfields extracted from 4-minute accelerated vs. 8-minute high-resolution T2-weighted 3T MRI scans.
    Cong S; Risacher SL; West JD; Wu YC; Apostolova LG; Tallman E; Rizkalla M; Salama P; Saykin AJ; Shen L
    Brain Imaging Behav; 2018 Dec; 12(6):1583-1595. PubMed ID: 29305751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study.
    Kinnunen KM; Cash DM; Poole T; Frost C; Benzinger TLS; Ahsan RL; Leung KK; Cardoso MJ; Modat M; Malone IB; Morris JC; Bateman RJ; Marcus DS; Goate A; Salloway SP; Correia S; Sperling RA; Chhatwal JP; Mayeux RP; Brickman AM; Martins RN; Farlow MR; Ghetti B; Saykin AJ; Jack CR; Schofield PR; McDade E; Weiner MW; Ringman JM; Thompson PM; Masters CL; Rowe CC; Rossor MN; Ourselin S; Fox NC;
    Alzheimers Dement; 2018 Jan; 14(1):43-53. PubMed ID: 28738187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.
    Ridha BH; Anderson VM; Barnes J; Boyes RG; Price SL; Rossor MN; Whitwell JL; Jenkins L; Black RS; Grundman M; Fox NC
    J Neurol; 2008 Apr; 255(4):567-74. PubMed ID: 18274807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease.
    Shen Q; Loewenstein DA; Potter E; Zhao W; Appel J; Greig MT; Raj A; Acevedo A; Schofield E; Barker W; Wu Y; Potter H; Duara R
    Alzheimers Dement; 2011 Jul; 7(4):e101-8. PubMed ID: 21784342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of Brain Volume Changes in Longitudinal Voxel-Based Morphometry Between Non-Accelerated and Accelerated Magnetic Resonance Imaging.
    Takao H; Amemiya S; Abe O;
    J Alzheimers Dis; 2021; 83(1):281-290. PubMed ID: 34308908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using high-dimensional machine learning methods to estimate an anatomical risk factor for Alzheimer's disease across imaging databases.
    Casanova R; Barnard RT; Gaussoin SA; Saldana S; Hayden KM; Manson JE; Wallace RB; Rapp SR; Resnick SM; Espeland MA; Chen JC;
    Neuroimage; 2018 Dec; 183():401-411. PubMed ID: 30130645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months.
    Schott JM; Price SL; Frost C; Whitwell JL; Rossor MN; Fox NC
    Neurology; 2005 Jul; 65(1):119-24. PubMed ID: 16009896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy.
    Fiford CM; Manning EN; Bartlett JW; Cash DM; Malone IB; Ridgway GR; Lehmann M; Leung KK; Sudre CH; Ourselin S; Biessels GJ; Carmichael OT; Fox NC; Cardoso MJ; Barnes J;
    Hippocampus; 2017 Mar; 27(3):249-262. PubMed ID: 27933676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.